CompoAtlas

樂活源膜衣錠

樂活源膜衣錠 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
ROYAL JELLYROYAL JELLYGelée royale
COENZYME Q10 POWDER (FERMENTED)COENZYME Q10 POWDER (FERMENTED)Not identified
SESAME EXTRACTSESAME EXTRACTNot identified
EVENING PRIMROSE EXTRACTEVENING PRIMROSE EXTRACTNot identified
JUJUBE FRUIT POWDERJUJUBE FRUIT POWDERNot identified
DEXTRINDEXTRINNot identified
HEME IRONHEME IRONFer
FOLIC ACIDFOLIC ACIDFolates (vitamine B9)
D-ALPHA-TOCOPHEROLD-ALPHA-TOCOPHEROLVitamine E
GUM ARABICGUM ARABICNot identified
SORBITAN FATTY ACID ESTERSORBITAN FATTY ACID ESTERNot identified
GLYCERIN FATTY ACID ESTERGLYCERIN FATTY ACID ESTERNot identified
CYANOCOBALAMINCYANOCOBALAMINVitamine B12
MALTODEXTRINMALTODEXTRINMaltodextrine
SODIUM CITRATESODIUM CITRATENot identified
CITRIC ACIDCITRIC ACIDAcide citrique
MALTOSEMALTOSENot identified
MICROCRYSTALLINE CELLULOSEMICROCRYSTALLINE CELLULOSENot identified
CALCIUM STEARATECALCIUM STEARATENot identified
SILICON DIOXIDESILICON DIOXIDENot identified
CARMINECARMINENot identified
GUAR GUMGUAR GUMNot identified
SHELLACSHELLACNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1096607173
Chinese name
樂活源膜衣錠
English name
SPIRITWLL FILM TABLET
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
富山生醫有限公司
Registration date
2020-10-19
Published validity end
2030-10-19

Original register data

View published fields and their variants
Product name
樂活源膜衣錠
Active ingredients
ROYAL JELLY;;COENZYME Q10 POWDER (FERMENTED);;SESAME EXTRACT;;EVENING PRIMROSE EXTRACT;;JUJUBE FRUIT POWDER;;DEXTRIN;;HEME IRON;;FOLIC ACID;;D-ALPHA-TOCOPHEROL;;GUM ARABIC;;SORBITAN FATTY ACID ESTER;;GLYCERIN FATTY ACID ESTER;;DEXTRIN;;CYANOCOBALAMIN;;MALTODEXTRIN;;SODIUM CITRATE;;CITRIC ACID;;MALTOSE;;MALTODEXTRIN;;MICROCRYSTALLINE CELLULOSE;;CALCIUM STEARATE;;SILICON DIOXIDE;;CARMINE;;GUAR GUM;;SHELLAC;;
Valid until
1191019
Registration number
1096607173
Licence holder
富山生醫有限公司
Registration date
1091019
Published reference
DHC0A966071731
Published English name
SPIRITWLL FILM TABLET

Official source

View the official register, number 1096607173

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ROYAL JELLY
    Read the warning, when it applies and the studies cited

    ROYAL JELLY

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Contraindications

    Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).

    Sources cited by Health Canada (8)
    • Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Case report
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).

    Sources cited by Health Canada (6)
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “樂活源膜衣錠”, https://compoatlas.com/en/supplements/taiwan/1096607173-spiritwll-film-tablet, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line